Contract with Customer, Liability, Current in USD of POINT Biopharma Global Inc. from Q4 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
POINT Biopharma Global Inc. quarterly Contract with Customer, Liability, Current history and change rate from Q4 2021 to Q3 2023.
  • POINT Biopharma Global Inc. Contract with Customer, Liability, Current for the quarter ending 30 Sep 2023 was $12.6M.
Contract with Customer, Liability, Current, Quarterly (USD)

POINT Biopharma Global Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2023 $12.6M 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $15.9M 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $16.5M 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $23.2M +$23.2M 31 Dec 2022 10-Q 13 Nov 2023
Q4 2021 $0 31 Dec 2021 10-K 27 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.